Profile data is unavailable for this security.
About the company
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.
- Revenue in USD (TTM)7.63bn
- Net income in USD739.00m
- Incorporated1996
- Employees45.00k
- LocationQuest Diagnostics Inc500 Plaza DrSECAUCUS 07094-3619United StatesUSA
- Phone+1 (973) 520-2700
- Fax+1 (302) 655-5049
- Websitehttps://www.questdiagnostics.com/
Mergers & acquisitions
| Acquired company | DGX:NYQ since announced | Transaction value |
|---|---|---|
| Boyce & Bynum Pathology Laboratories-Clinical laboratory services business | -7.10% | -- |
| Marin General Hospital-Outreach Laboratory Service Operations | -3.67% | -- |
| PhenoPath Laboratories PLLC | -18.03% | -- |
| Oxford Immunotec Global PLC-Laboratory Services Business | -18.12% | 170.00m |
| Reprosource Inc | -18.13% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Encompass Health Corp | 4.19bn | 325.50m | 7.17bn | 29.37k | 22.21 | 5.44 | 11.77 | 1.71 | 3.26 | 3.25 | 42.03 | 13.33 | 0.837 | -- | 9.32 | 142,706.80 | 8.31 | 8.31 | 10.49 | 10.05 | 96.27 | 95.85 | 9.93 | 10.24 | -- | 5.00 | 0.5826 | 30.82 | 7.49 | 12.92 | 4.17 | 10.87 | 8.94 | -- |
| Molina Healthcare, Inc. | 19.18bn | 298.00m | 8.47bn | 20.00k | 35.28 | 5.39 | 19.20 | 0.4417 | 3.85 | 2.88 | 299.73 | 25.18 | 2.26 | -- | 16.33 | 958,750.00 | 3.50 | -0.5835 | 10.22 | -1.34 | 16.11 | 13.97 | 1.55 | -0.2285 | -- | 7.52 | 0.4922 | -- | 11.82 | 27.44 | -980.77 | -- | 1.93 | -- |
| Davita Inc | 11.36bn | 364.80m | 9.56bn | 74.50k | 26.76 | 2.50 | 8.44 | 0.8409 | 2.15 | 3.34 | 63.66 | 23.04 | 0.5924 | 66.06 | 5.77 | 152,545.50 | 2.75 | 4.53 | 3.75 | 5.61 | 28.64 | 29.56 | 4.64 | 6.76 | 1.82 | 3.34 | 0.6675 | 0.00 | 1.58 | 5.85 | -36.71 | 4.15 | 10.47 | -- |
| Universal Health Services, Inc. | 10.66bn | 810.32m | 11.94bn | 76.60k | 15.02 | 2.23 | 9.34 | 1.12 | 8.59 | 8.91 | 113.05 | 57.98 | 0.973 | -- | 7.12 | 139,171.90 | 7.57 | 7.28 | 8.93 | 8.59 | -- | -- | 7.78 | 7.59 | 1.01 | 8.26 | 0.4251 | 5.25 | 6.59 | 8.38 | 2.83 | 10.26 | 7.03 | 14.87 |
| Quest Diagnostics Inc | 7.63bn | 739.00m | 11.99bn | 45.00k | 16.59 | 2.25 | 10.94 | 1.57 | 5.31 | 6.17 | 54.78 | 39.10 | 0.7121 | 49.36 | 7.42 | 169,511.10 | 7.42 | 7.39 | 8.48 | 8.50 | 36.90 | 38.90 | 10.42 | 9.66 | 1.09 | 10.89 | 0.4046 | 31.71 | 2.58 | 0.8691 | 3.27 | 1.10 | 6.70 | 17.32 |
| WellCare Health Plans, Inc. | 18.69bn | 388.50m | 12.12bn | 8.90k | 28.86 | 2.91 | 22.38 | 0.6485 | 8.40 | 9.64 | 406.27 | 83.28 | 1.73 | -- | -- | 2,099,820.00 | 3.60 | 3.70 | -- | -- | -- | -- | 2.08 | 1.36 | -- | 211.11 | 0.338 | 0.00 | 19.46 | 18.08 | 31.19 | 11.45 | 15.95 | -- |
| Laboratory Corp. of America Holdings | 11.34bn | 928.50m | 14.22bn | 60.00k | 15.67 | 1.97 | 9.55 | 1.25 | 8.99 | 13.85 | 109.77 | 71.48 | 0.6801 | 35.64 | 6.16 | 189,036.70 | 5.58 | 5.55 | 6.28 | 6.36 | 29.27 | 34.43 | 8.21 | 7.43 | 1.44 | 5.92 | 0.4707 | -- | 8.29 | 12.98 | 2.34 | 5.14 | 12.34 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2018 | 14.30m | 10.51% |
| BlackRock Fund Advisorsas of 30 Sep 2018 | 7.52m | 5.53% |
| Macquarie Investment Management Business Trustas of 30 Sep 2018 | 6.70m | 4.92% |
| SSgA Funds Management, Inc.as of 30 Sep 2018 | 6.32m | 4.64% |
| Marshall Wace North America LPas of 30 Sep 2018 | 4.19m | 3.08% |
| American Century Investment Management, Inc.as of 30 Sep 2018 | 4.11m | 3.02% |
| Fiduciary Management, Inc.as of 30 Sep 2018 | 4.09m | 3.01% |
| Victory Capital Management, Inc.(Investment Management)as of 30 Sep 2018 | 2.68m | 1.97% |
| Dimensional Fund Advisors LPas of 30 Sep 2018 | 1.97m | 1.45% |
| Bessemer Investment Management LLCas of 30 Sep 2018 | 1.95m | 1.43% |
